pro re nata dosing groupĀ  n = 57 scheduled dosing group n = 56
Somnolence 51 (89 %) 39 (70%)
Vomiting 7 (12 %) 13 (23%)
Nausea 12 (21 %) 16 (29%)
Epigastric pain 7 (12 %) 5 (9%)
Abdominal pain 7 (12 %) 10 (18%)
Headache 11 (19 %) 13 (23%)
Dizziness 18 (32 %) 18 (32%)
Fever 5 (9 %) 4 (7%)
Other* 1 (1 %) 7 (13%)
Total number of adverse-events 120 125
Number of children with one or more adverse events 52 (91%) 44 (79%)
Data are presented as number of cases (%), n=113.
*diplopia (n=3), diarrhoea (n=2), throat sore (n=2), upper respiratory track infection (n=1), nervousness (n=1).
Table 2: Adverse events after discharge in the two study groups.